From 17-19 November at Fi Europe 2026 in Frankfurt, Germany, Clasado Biosciences will be meeting with food and nutrition experts to discuss how science-backed prebiotic ingredients and formulation expertise can help bring targeted gut health products to market.  

At the centre of this conversation is Bimuno® GOS, Clasado’s proprietary galactooligosaccharide (GOS) prebiotic, backed by an extensive body of scientific research and clinical studies. Bimuno GOS has been investigated for its effects on gut microbiota and its potential role in supporting gastrointestinal health and other aspects of health and wellbeing. 

As interest in gut health continues to grow, the sector can expect more opportunities across the food and nutrition market as brands search for ingredients that combine scientific credibility with practical formulation options.  

Bimuno GOS can be incorporated into a range of applications including functional foods, beverages, food supplements, and active nutrition products, offering excellent flexibility for product developers working across different applications. The stability of Bimuno GOS under processing conditions, including heat and acidity, further enables formulators to explore new product concepts while accounting for manufacturing requirements.  

Annika Malmros, Business Development Director for EMEA, said: “Prebiotic innovation is about more than identifying promising ingredients. It is critical to understand the science and how it translates into products that meet consumer needs and market trends.  

“At Fi Europe, we’re looking forward to speaking with brands and formulators about the opportunities for Bimuno GOS across food, beverage and nutrition applications, and how our scientific expertise and formulation support can help bring differentiated, evidence-led gut health concepts to life.” 

Click here to schedule a meeting with the Clasado team at Fi Europe 2026.